Navigation Links
Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer
Date:6/6/2008

xpression in various pathological conditions. As a result, these differences may provide for a novel diagnostic strategy for many diseases.

About Rosetta Genomics

Rosetta Genomics (Nasdaq: ROSG) is a leader in the field of microRNAs. Founded in 2000, the company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development of a full range of microRNA-based diagnostic and therapeutic tools, focusing primarily on cancer and various women's health indications. The company expects that the first microRNA diagnostic tests applying its technology will be launched by licensed clinical laboratories in the United States in 2008.

Forward-Looking Statement Disclaimer

Various statements in this release concerning Rosetta's future expectations, plans and prospects, including without limitation, statements relating to the role of microRNAs in human physiology and disease, the potential of microRNAs in the diagnosis and treatment of disease and the Company's ability to successfully develop lung cancer diagnostic tests, specifically, through identifying unique microRNA signatures that may predict risk of recurrence in stage I and II Non Small Cell Lung Cancer (NSCLC) patients, constitute forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, i
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
2. Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Companys MicroRNA Technology
3. Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
7. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
8. M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients
9. Fals-Stewart Earns Hazeldens 2007 Dan Anderson Research Award
10. Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015 ... für kongestive Herzinsuffizienz (CHF) in seiner ersten ...     Die israelische ... Herzüberwachungssystem für Patienten mit kongestiver Herzinsuffizienz (CHF) ... ein Finanzierungsvorhaben über 5 Mio. USD abgeschlossen ...
(Date:2/27/2015)... Feb. 27, 2015  Two mass spectrometry ... applications as their effectiveness is established, according ...  Kalorama Information says that while mass spectrometry ... powerful tool in proteomic biomarker discovery and ... its traditional techniques has struggled to elucidate ...
(Date:2/26/2015)... , Feb. 26, 2015  AbbVie (NYSE: ... of studies in its neuroscience and oncology development ... 67 th American Academy of Neurology annual ... from April 18-25. The accepted abstracts feature results ... addition to investigational treatments in AbbVie,s pipeline. Presentations ...
Breaking Medicine Technology:Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7
... Shire plc (LSE: SHP, Nasdaq: SHPGY ), ... a 5-aminosalicylic acid (5-ASA) persistency analysis entitled, "Twelve-month Persistence ... Database," at Digestive Disease Week, on May 31, 2009. ... continuing patients, 20 percent of Lialda patients were continually ...
... Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN ... 1 safety and efficacy results following administration of ... with high-risk genomic factors and relapsed or refractory ... proprietary anti-CD37 Small Modular ImmunoPharmaceutical (SMIP(TM)) product candidate. ...
Cached Medicine Technology:Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week 2Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week 3Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week 4Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week 5Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL) 2Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL) 3Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL) 4Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL) 5
(Date:2/27/2015)... The Dawn Greene Hospice, a 10-bed facility located ... on the Upper East Side, was officially dedicated and blessed ... Eminence Timothy Michael Cardinal Dolan. , Thomas J. Fahey, Jr., ... a member of the ArchCare Board of Trustees, presided over ... executive director of MMW, and Christina McInerney, president and CEO ...
(Date:2/27/2015)... FACE Skincare~Medical~Wellness, a multiaward-winning leader in bringing ... to take fifteen years off of an individual’s ... treatment introduced that is the first and only ... lines and wrinkles on the Décolleté. This new ... the stubborn vertical lines between the upper breast ...
(Date:2/27/2015)... Mediaplanet today announces the launch of its second cross-platform ... bring blood health and cancer awareness to the forefront ... edition go beyond the concept of these insidious diseases ... and technological strides needed to develop new solutions and ... every 3 minutes one person in the United ...
(Date:2/27/2015)... February 27, 2015 Glidewell Laboratories, ... the launch of its CloudPoint™ family ... digital production of monolithic zirconia crowns & bridges, ... of providing the CAD/CAM-produced restorations that doctors demand. ... through which cases can be scanned, managed and ...
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 ... who have suffered from injuries or diseases affecting ... team of physicians are located throughout Southern California, ... medical procedures to treat conditions related to the ... Dr. Edwin M. Ashley are board-certified and fully ...
Breaking Medicine News(10 mins):Health News:The Dawn Greene Hospice Is Officially Dedicated 2Health News:The Dawn Greene Hospice Is Officially Dedicated 3Health News:Face Skincare Announces New Combination Therapy 2Health News:Know Your Blood: Raising Awareness through Mediaplanet’s “Blood Health” Campaign 2Health News:Glidewell Laboratories Announces Release of CloudPoint™ FastScan™ and FastDesign™ 2Health News:Glidewell Laboratories Announces Release of CloudPoint™ FastScan™ and FastDesign™ 3Health News:Healthpointe is Now Performing Arthroscopic Surgery Techniques for Elbow, Hand and Wrist Injuries and Diseases, such as certain Ganglion Cysts 2
... Conn, Nov. 20 Purdue Pharma L.P. and Mundipharma ... into a global strategic alliance with Infinity Pharmaceuticals, Inc. ... discovery and early clinical programs in the areas of ... , The alliance will focus on ...
... year, the American Pain,Society (APS), http://www.ampainsoc.org , will ... Clinical Centers of Excellence in Pain,Management Awards Program. ... The Clinical Centers ... of healthcare professionals who are satisfying,unmet critical needs in ...
... KANSAS CITY, Mo., Nov. 20 Does this look familiar?,Bailouts, ... stores are ghost towns, and everyone is uninsured without a,retirement ... and,find anything to be optimistic about. , ... We are facing tough economic ...
... Chemotherapy figures alone may differ by almost $37,000 per ... -- The cost of treating colorectal cancer can vary ... To reach that conclusion, researchers compared the eight most ... 400 patients at 115 ambulatory care centers across the ...
... Elizabeth T. H. (Terry) Fontham, MPH, DrPH, Dean of the LSU ... the first non-physician elected national President of the American Cancer Society ... National Assembly Meeting on November 20, 2008 in New York City. ... female to serve as president in the organization,s 96-year history., ...
... Polling of Americans and Industry Thought Leaders Finds Competing ... Nov. 20 /PRNewswire-USNewswire/ -- Three-quarters of Americans ... major health care reform legislation to be passed in ... findings of new polling released today by the National ...
Cached Medicine News:Health News:Purdue Pharma L.P. Announces a Global Strategic Alliance With Infinity Pharmaceuticals to Advance Discovery and Development Programs in Oncology and Neuropathic Pain 2Health News:American Pain Society Accepting Applications for Clinical Centers of Excellence in Pain Management Awards 2Health News:Don't Let Economic Struggles Destroy Your Teeth 2Health News:Colorectal Cancer Treatment Costs Vary Widely 2Health News:LSUHSC's Fontham makes history 2Health News:LSUHSC's Fontham makes history 3Health News:Three-Quarters of Americans and Industry Leaders Want Health Care Reform in President-elect Obama's First Term 2Health News:Three-Quarters of Americans and Industry Leaders Want Health Care Reform in President-elect Obama's First Term 3Health News:Three-Quarters of Americans and Industry Leaders Want Health Care Reform in President-elect Obama's First Term 4Health News:Three-Quarters of Americans and Industry Leaders Want Health Care Reform in President-elect Obama's First Term 5Health News:Three-Quarters of Americans and Industry Leaders Want Health Care Reform in President-elect Obama's First Term 6